First Division of Nephrology, Department of Translational Medical Sciences, School of Medicine, University of Campania "Luigi Vanvitelli", Via Pansini 5, Bldg 17, 80131, Naples, Italy.
Nephrology Section, Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent, Belgium.
J Nephrol. 2019 Oct;32(5):733-740. doi: 10.1007/s40620-019-00589-z. Epub 2019 Jan 23.
The gut microbiota is considered to be a novel important factor to take into account in the pathogenesis of chronic kidney disease and uremia. Much attention has been paid to specific uremic retention solutes of microbial origin, such as indoxyl sulfate, p-cresyl sulfate, and trimethylamine-N-oxide. However, other novel less well studied compounds, such as hydrogen sulfide and related sulfur metabolites (sulfane sulfur, lanthionine, etc.), should be included in a more comprehensive appraisal of this topic, in light of the potential therapeutic opportunities for the future.
肠道微生物群被认为是慢性肾脏病和尿毒症发病机制中需要考虑的一个新的重要因素。人们非常关注微生物来源的特定尿毒症潴留溶质,如吲哚硫酸酯、对甲酚硫酸酯和三甲胺 N-氧化物。然而,鉴于未来可能存在的治疗机会,应该在更全面的评估中纳入其他一些新的研究较少的化合物,如硫化氢和相关的硫代谢物(硫磺酸、硫氨酸等)。